F. Francesconi

Immunologic Biomarkers for Clinical and Therapeutic Management of Psoriasis

E. Berardesca, S. Chimenti, A. Orlandi, 2014, Mediators of inflammation.

Safety of antitumour necrosis factor‐α therapy in psoriatic patients with hepatitis B virus infection

E. Berardesca, C. Bonifati, A. Morrone, 2010, The British journal of dermatology.

High prevalence of latent tuberculosis infection in autoimmune disorders such as psoriasis and in chronic respiratory diseases, including lung cancer.

M. Filippetti, E. Berardesca, V. Bordignon, 2011, Journal of biological regulators and homeostatic agents.

Psoriasis, Kaposi’s Sarcoma and Hodgkin’s Disease in a Patient with Down’s Syndrome

S. Uccini, S. Chimenti, K. Peris, 2004, Dermatology.

The diagnosis of early psoriatic arthritis in an outpatient dermatological centre for psoriasis

C. Bonifati, F. Solivetti, F. Francesconi, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825.

S. Amadori, S. Fratoni, G. del Poeta, 2006, Blood.

Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.

P. Visca, C. Bonifati, G. Trevisan, 2010, Dermatology online journal.

Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review

A. Gemignani, G. Orrú, C. Conversano, 2020, International journal of environmental research and public health.

hMena: altered expression in psoriatic skin

C. Cota, D. Kovacs, C. Bonifati, 2013, Archives of Dermatological Research.